Press Release

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Infertility Drugs Market to Grow at a CAGR of 6.20% During 2022-2027, Aided by the Rising Cases of Infertility

According to a new report by EMR titled, ‘Global Infertility Drugs Market Report and Forecast 2022-2027’, the market is expected to witness a healthy growth, expanding at a CAGR of 6.20% between 2022 and 2027.

The infertility drugs industry is driven by the rising cases of infertility due to changing lifestyle. In females, the growing hormonal issues and other medical conditions, which prevents ovulation, abnormal menstrual cycle, and others, can contribute to female infertility while in men, disruption of testicular or ejaculatory function, genetic disorders, and others contribute to infertility. The growing trust of people seeking fertility treatment on drugs and medications owing to their reduced side-effects and cost-effectiveness is likely to be a major factor contributing to the increased demand in the forecast period. Furthermore, the growing concerns pertaining to low population in some countries are likely to instigate the market growth in the forecast period.

The growing collaborations among the major industry players are expected to aid the market growth. In January 2021, Royal Phillips (NYSE: PHG) announced a multi-year collaboration with Merck KGaA (ETR: MRK). This partnership is aimed towards the development of clinical grade digital solutions for highly personalised fertility treatment.

In terms of region, the market in North America is anticipated to witness a considerable growth in the forecast period. The market in the region is driven by factors such as the presence of advanced medical facilities and the rising FDA approvals of new drugs. However, illegal sales of the drugs may hamper the market growth.

Market Breakup by Drug Class, End User, Distribution Channel, and Region:

  • The market is segmented based on drug class into gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and biguanides, among others.
  • Based on end user, the market is bifurcated into male and female.
  • The major distribution channels considered in the market include hospital pharmacies, and retail pharmacies, among others.
  • Region-wise, the global market for infertility drugs can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The global market for infertility drugs is being driven by the rising cases of infertility among male and female due to unhealthy and busy lifestyles.
  • The growing awareness about infertility treatment, coupled with the rising healthcare expenditure by governments in emerging economies, is likely to be a major driving factor for the market.
  • The increasing FDA approvals as well as the growing trust on infertility drugs are likely to provide impetus to the market.
  • The market is expected to be further aided by the growing research and development activities and the rising investments to improve healthcare infrastructure. 

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for infertility drugs for the periods (2017-2021) and (2022-2027). 
  • The report also offers historical (2017-2021) and forecast (2022-2027) market information for the drug class, end users, distribution channels, and regions of infertility drugs.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global infertility drugs market are Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., and Ferring Pharmaceuticals Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER